Core Insights - Hims & Hers Health, Inc. has launched Labs, a new service aimed at helping customers understand and improve their overall health [1][2] - The company anticipates that this offering could evolve into a $1 billion business, targeting a broad market [5] Product Offering - Labs measures key health markers over time and provides doctor-developed action plans, focusing on areas such as heart health, metabolism, hormones, inflammation, and stress [2][6] - Two plans are available: - Base plan includes one yearly blood draw with 50 biomarker tests for $199 - Advanced plan includes two yearly blood draws with over 120 biomarker tests for $499 [4][7] Market Access and Strategy - Customers will access testing at over 1,000 Quest Diagnostics locations nationwide, receiving results and personalized plans through the Hims & Hers platform [6] - The company plans to expand its offerings to include at-home testing devices and additional biomarker tests in areas like bone and brain health [3] Financial Performance - For the third quarter, Hims & Hers reported revenue of $598.97 million, surpassing the estimate of $580.24 million, with a 21% year-over-year increase in subscribers to nearly 2.5 million [8] - The company projects fourth-quarter revenue between $605 million and $625 million, slightly below the analyst estimate of $631.68 million [8]